14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for CRIS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 17.46 5.75 %
R2 17.10 3.57 %
R1 16.88 2.22 %
Current price: 16.51
Support S1 16.15 -2.16 %
S2 15.93 -3.51 %
S3 15.57 -5.69 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 16.80 1.76 %
Current price 16.51
Support S1 16.01 -3.03%
S2 15.58 -5.63%
S3 12.68 -23.20%

CRIS Predictions History

3 years ago
Richard Giles predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Gareth Payne predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Michael Mengistu predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Derek McDaniel predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Todd Mace predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Reet Paul Gill predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
andrewj.smith1998 predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Jimmy Robbins predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Jeffery P Hodges predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Heather Ditch predicted that CRIS for 2021-02-17 is going

Rank:
Click to get the best stock tips daily for free!

About Curis

Curis Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize t... CRIS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT